Effect of obesity and troglitazone on expression of two glutathione peroxidases: cellular and extracellular types in serum, kidney and adipose tissue.
To determine the effect of obesity on expression of cellular- (C-) and extracellular (EC-) glutathione peroxidase (GPX) in serum, kidney and adipose tissue, we measured GPX in serum, kidneys and adipose tissue of the obese Otsuka-Long-Evans-Tokushima Fatty (OLETF) rat and its lean counterpart (LETO). We also investigated the effect of troglitazone. Five each of OLETF and LETO rats were fed diet with or without 0.2% troglitazone for 10 days. Final body weight, kidney weight, blood glucose and serum tumor necrosis factor-alpha (TNF-alpha) level were higher in OLETF rats than in LETO rats. Serum and kidney GPX activities were higher, but adipose tissue GPX activity was lower, in OLETF rats than in LETO rats. Troglitazone treatment decreased adipose tissue GPX activity and abolished overproduction of TNF-alpha in OLETF rats. Immunoblot analysis, for the first time, revealed that both obesity and troglitazone suppressed the protein signals for C-GPX and EC-GPX in adipose tissue. Serum protein carbonyl groups were increased in OLETF rats and troglitazone completely blocked this increase. Increased serum GPX activity in obese rat was due to the increased secretion of EC-GPX from the kidney. Troglitazone protected against the enhanced oxidative stress induced by obesity independently of the serum GPX concentration.
Asayama
K
K
Department of Pediatrics, Yamanashi Medical University, 1110 Shimokato, Tamahocho, Nakakomagun, Yamanashi 409-3898, Japan. kasayama@med.uoeh-u.ac.jp
Nakane
T
T
Dobashi
K
K
Kodera
K
K
Hayashibe
H
H
Uchida
N
N
Nakazawa
S
S
D000273:Adipose Tissue / Q000201:enzymology*; D000818:Animals; D001786:Blood Glucose; D015153:Blotting, Western; D001835:Body Weight / Q000187:drug effects / Q000235:genetics; D002839:Chromans / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects* / Q000235:genetics; D005979:Glutathione Peroxidase / Q000097:blood / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology* / Q000473:pathology; D008297:Male; D009765:Obesity / Q000201:enzymology*; D009929:Organ Size / Q000187:drug effects / Q000235:genetics; D051381:Rats; D020334:Rats, Inbred OLETF; D011919:Rats, Inbred Strains; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013844:Thiazoles / Q000494:pharmacology*; D045162:Thiazolidinediones; D000077288:Troglitazone; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D001786:Blood Glucose; D002839:Chromans; D013844:Thiazoles; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D005979:Glutathione Peroxidase; D000077288:Troglitazone